Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Sunshine Biopharma, Inc | sbfm_8k.htm |
Exhibit 16.2
February 25, 2013
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Sunshine Biopharma, Inc.
On February 25, 2013 my appointment as auditor for Sunshine Biopharma, Inc. ceased. I have read Sunshine Biopharma, Inc.’s statements included under Item 4.01 of its Form 8-K dated February 25, 2013 and agree with such statements, insofar as they apply to me.
Very truly yours,
Borgers & Cutler CPA’s PLLC
Certified Public Accountants
Denver, CO